Tavio Capital’s Medpace MEDP Stock Holding History

Tavio Capital’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-126,887	Closed	-$7.48M	–	13
2019 Q1	$7.48M	Hold	126,887	–	–	2.76%	9
2018 Q4	$6.72M	Buy	126,887 +40,217	+46%	+$2.21M	2.79%	11
2018 Q3	$5.19M	Buy	+86,670	New	+$4.74M	2.03%	15

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BHG

Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Tavio Capital's MEDP Position: Q2 2019 in Review

Tavio Capital sold out of Medpace (MEDP) in Q2 2019, closing a stake of 126,887 shares — an estimated $7.48M sold.

Tavio Capital first reported a position in MEDP in Q3 2018 and held it in 3 quarters. The position peaked at $7.48M in Q1 2019. 225 funds tracked by Wall St. Rank hold MEDP as of Q2 2019.

Tavio Capital reported no remaining Medpace position as of Q2 2019 after selling out during the quarter.
Tavio Capital sold 126,887 Medpace shares in Q2 2019, an estimated $7.48M.
Tavio Capital first reported a position in Medpace in Q3 2018 and held it in 3 quarters.
Tavio Capital's Medpace position peaked at $7.48M in Q1 2019.
225 funds tracked by Wall St. Rank held Medpace as of Q2 2019.

Based on Tavio Capital's 13F filing for Q2 2019, filed 13 Aug 2019.